bioAffinity Technologies reports preclinical siRNA findings for skin cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. NVDA
4. USO
5. TSLA
6. GNK
7. PLUR
8. MU
9. ARGX
10. AZN

Go back to bioAffinity Technologies reports preclinical siRNA findings for skin cancer

bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells

June 22, 2026 8:00 AM EDT

Research suggests a potential topical treatment for common skin cancers, squamous cell and basal cell carcinoma

Findings will be presented at 2026 RNA Therapeutics Symposium June 24-26

SAN ANTONIO--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage cancer diagnostics and... More